Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Cymraeg
Cymraeg
Search
Menu
Home
Accessing medicines
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh Medicines Advice Service
Welsh National Poisons Unit
Sodium valproate information hub
Your Medicines Your Health
Work in progress
VPAG Programme
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Our committees
Who we are
What we do
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
Files
›
Guidelines and PILs
Guidelines and PILs
24/12/2021
Tramadol educational resources -Review 2021 Appendix 3 (1).docx
24/12/2021
Tramadol educational resources -Review 2021 Appendix 2 (1).docx
24/12/2021
Tramadol educational resources -Review 2021 Appendix 1 (1).docx
24/12/2021
Tramadol Educational Resource Materials (PIL).pdf
24/12/2021
Tramadol educational resources - Review 2021.pdf
26/10/2021
Patient access to NRT while in hospital - Brief guide for wards.docx
26/10/2021
Prescribing Dilemmas - A Guide for Prescribers.pdf
26/10/2021
Material to Support Appropriate Prescribing of Hypnotics and Anxiolytics across Wales - Appendix 5.docx
26/10/2021
Material to Support Appropriate Prescribing of Hypnotics and Anxiolytics across Wales - Appendix 4.docx
26/10/2021
Material to Support Appropriate Prescribing of Hypnotics and Anxiolytics across Wales - Appendix 3.docx
26/10/2021
Material to Support Appropriate Prescribing of Hypnotics and Anxiolytics across Wales - Appendix 2.docx
26/10/2021
Material to Support Appropriate Prescribing of Hypnotics and Anxiolytics across Wales - Appendix 1.docx
11/10/2021
All Wales advice on sodium-glucose cotransporter-2 (SGLT-2) inhibitors in type 2 diabetes and cardiovascular disease - patient characteristic considerations
11/10/2021
All Wales advice on sodium-glucose cotransporter-2 (SGLT-2) inhibitors in type 2 diabetes and cardiovascular disease
17/05/2021
Welsh National Standards for Medication Review.pdf
17/05/2021
Welsh National Standards for Medication Review - Brief Guide.pdf
17/05/2021
Safeguarding Users of Opioid Patches.pdf
24/02/2021
Generic shared care template and agreement form.docx
24/02/2021
Prescribing Dilemmas - A Guide for Prescribers.pdf
01/02/2021
Initial clinical management of adult smokers in secondary care.pdf
5
6
7
8
9
10
11
12
13
14
15
Follow AWTTC: